A Connecticut company is using a drug it developed to try and fight against COVID-19.

Sen. Chris Murphy visited AI Therapeutics in Guilford Tuesday, which has developed the new drug Apilimod to treat non-Hodgkin lymphoma and Lou Gehrig's disease.

The company says it has just been approved for phase two clinical trials with COVID-19 patients.

Murphy says when it comes to battling the pandemic, we can't pin all of our hopes or efforts on a future vaccine.

Researchers say early tests are promising for preventing an infected person from developing pneumonia, but that the drug may also be able to prevent infection before it happens.